Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Peter Clark MD

Peter E. Clark MD

Associate Professor, Urologic Surgery; Residency Program Director, Vanderbilt University Medical Center, Nashville, Tennessee

Dr. Clark received his undergraduate degree in Biology from Cornell University and went on to complete his medical degree at Harvard Medical School. He completed his urologic residency at the Cleveland Clinic Foundation and subsequently did his urologic oncology fellowship training at the University of Southern California. He is currently Professor and Chairman of the Department of Urology at Carolinas Healthcare System and Chair of Urologic Oncology at the Levine Cancer Institute in Charlotte NC, having moved from Vanderbilt University where he was also the Residency Program Director. Dr. Clark has an active clinical practice focused primarily on bladder and kidney cancer as well as an active interest in the basic sciences, particularly the role of MAPK’s and canonical Wnt signaling on kidney and bladder oncogenesis. Until recently he was Chair of the bladder/Penile cancer guidelines panel for the National Comprehensive Cancer Network (NCCN) and is a member of non-muscle invasive bladder cancer and small renal mass guidelines panels for the American Urologic Association (AUA). He is serving as the representative for the Southeast Section of the AUA to the AUA Foundation Research Council, the Research, Education, and Communication Committee, the Judicial and Ethics Committee, the Practice Guidelines Committee (where he serves as Vice Chairman), and is on the editorial boards for the Journal of Urology, BJUI, Urologic Oncology, and UROLOGY. He serves on the Examination Committee for the American Board of Urology. He is also an active member of the Society of Urologic Oncology (where he recently was chair of the Fellowship Committee), The Society of Academic Urologists, and the Society of Basic Urologic Research. He has over 170 publications in both the clinical and basic sciences.



Dr. Clark reports no diclosures.